17 Publications
2023
High-dose chemotherapy for relapsed testicular germ cell tumours
Chovanec, MichalChovanec, MichalAdra, NabilAdra, NabilAbu Zaid, MohammadAbu Zaid, MohammadAbonour, RafatAbonour, RafatEinhorn, Lawrence and Einhorn, Lawrence
Nature Reviews. Urology, vol. 20, (no. 4), pp. 217-225, Apr 2023. | Journal Article
2022
High-dose chemotherapy for relapsed testicular germ cell tumours.
Chovanec, MichalChovanec, MichalAdra, NabilAdra, NabilAbu Zaid, MohammadAbu Zaid, MohammadAbonour, RafatAbonour, RafatEinhorn, Lawrence and Einhorn, Lawrence
Nature reviews. Urology, December 7, 2022. | Journal Article
2021
Dipeptidyl Peptidase 4 Inhibition for Prophylaxis of Acute Graft-versus-Host Disease.
Farag, Sherif SFarag, Sherif SAbu Zaid, MohammadAbu Zaid, MohammadSchwartz, Jennifer ESchwartz, Jennifer ESchwartz, Jennifer EThakrar, Teresa CThakrar, Teresa CSchwartz, Jennifer EThakrar, Teresa CBlakley, Ann JThakrar, Teresa CBlakley, Ann JBlakley, Ann JBlakley, Ann JAbonour, RafatRobertson, Michael JAbonour, RafatRobertson, Michael JRobertson, Michael JRobertson, Michael JBroxmeyer, Hal EBroxmeyer, Hal EZhang, ShuhongZhang, ShuhongZhang, Shuhong and Zhang, Shuhong
The New England journal of medicine, vol. 384, (no. 1), pp. 11-19, January 7, 2021. | Journal Article
 
Survival outcomes and toxicity in patients 40 years old or older with relapsed metastatic germ cell tumors treated with high-dose chemotherapy and peripheral blood stem cell transplantation.
Agrawal, VaibhavAgrawal, VaibhavAgrawal, VaibhavAbonour, RafatAbonour, RafatAbonour, RafatAbu Zaid, MohammadAbu Zaid, MohammadAbu Zaid, MohammadAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KAshkar, RyanAshkar, RyanAshkar, RyanAlbany, CostantineAlbany, CostantineAlbany, CostantineHanna, Nasser HHanna, Nasser HHanna, Nasser HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HAdra, NabilAdra, Nabil and Adra, Nabil
Cancer, July 14, 2021. | Journal Article
2019
Adverse Health Outcomes in Relationship to Hypogonadism After Chemotherapy: A Multicenter Study of Testicular Cancer Survivors
Abu Zaid, MohammadAbu Zaid, MohammadAbu Zaid, MohammadDinh, Paul CDinh, Paul CDinh, Paul CMonahan, Patrick OMonahan, Patrick OMonahan, Patrick OFung, ChunkitFung, ChunkitFung, ChunkitEl-Charif, OmarEl-Charif, OmarEl-Charif, OmarFeldman, Darren RFeldman, Darren RFeldman, Darren RHamilton, Robert JHamilton, Robert JHamilton, Robert JVaughn, David JVaughn, David JVaughn, David JBeard, Clair JBeard, Clair JBeard, Clair JCook, RyanCook, RyanCook, RyanAlthouse, SandraAlthouse, SandraAlthouse, SandraArdeshir-Rouhani-Fard, ShirinArdeshir-Rouhani-Fard, ShirinArdeshir-Rouhani-Fard, ShirinSesso, Howard DSesso, Howard DSesso, Howard DHuddart, RobertHuddart, RobertHuddart, RobertMushiroda, TaiseiMushiroda, TaiseiMushiroda, TaiseiKubo, MichiakiKubo, MichiakiKubo, MichiakiDolan, M EileenDolan, M EileenDolan, M EileenEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HFossa, Sophie DFossa, Sophie DFossa, Sophie DTravis, Lois BTravis, Lois B and Travis, Lois B
Journal of the National Comprehensive Cancer Network : JNCCN, vol. 17, (no. 5), pp. 468, 2019-05-01. | Journal Article
 
Combination of sorafenib, vorinostat and bortezomib for the treatment of poor-risk AML: report of two consecutive clinical trials
Sayar, HamidSayar, HamidSayar, HamidCripe, Larry DCripe, Larry DCripe, Larry DSaliba, Antoine NSaliba, Antoine NSaliba, Antoine NAbu Zaid, MohammadAbu Zaid, MohammadAbu Zaid, MohammadKonig, HeikoKonig, HeikoKonig, HeikoBoswell, H. ScottBoswell, H. Scott and Boswell, H. Scott
Leukemia Research, vol. 77, pp. 33, February 2019. | Journal Article
 
Gene Co-expression Network and Copy Number Variation Analyses Identify Transcription Factors Associated With Multiple Myeloma Progression
Yu, Christina YYu, Christina YXiang, ShunianXiang, ShunianHuang, ZhiHuang, ZhiJohnson, Travis SJohnson, Travis SZhan, XiaohuiZhan, XiaohuiHan, ZhiHan, ZhiAbu Zaid, MohammadAbu Zaid, MohammadHuang, Kun and Huang, Kun
Frontiers in genetics, vol. 10, pp. 468, 2019-00-00. | Journal Article
2018
Combination of sorafenib, vorinostat and bortezomib for the treatment of poor-risk AML: report of two consecutive clinical trials
Sayar, HamidSayar, HamidSayar, HamidCripe, Larry DCripe, Larry DCripe, Larry DSaliba, Antoine NSaliba, Antoine NSaliba, Antoine NAbu Zaid, MohammadAbu Zaid, MohammadAbu Zaid, MohammadKonig, HeikoKonig, HeikoKonig, HeikoBoswell, H ScottBoswell, H Scott and Boswell, H Scott
Leukemia research, vol. 77, pp. 30, 2018-Dec-24. | Journal Article
 
Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study
Kerns, Sarah LKerns, Sarah LKerns, Sarah LKerns, Sarah LFung, ChunkitFung, ChunkitFung, ChunkitFung, ChunkitMonahan, Patrick OMonahan, Patrick OMonahan, Patrick OMonahan, Patrick OArdeshir-Rouhani-Fard, ShirinArdeshir-Rouhani-Fard, ShirinArdeshir-Rouhani-Fard, ShirinArdeshir-Rouhani-Fard, ShirinAbu Zaid, Mohammad IAbu Zaid, Mohammad IAbu Zaid, Mohammad IAbu Zaid, Mohammad IWilliams, AnnaLynn MWilliams, AnnaLynn MWilliams, AnnaLynn MWilliams, AnnaLynn MStump, Timothy EStump, Timothy EStump, Timothy EStump, Timothy ESesso, Howard DSesso, Howard DSesso, Howard DSesso, Howard DFeldman, Darren RFeldman, Darren RFeldman, Darren RFeldman, Darren RHamilton, Robert JHamilton, Robert JHamilton, Robert JHamilton, Robert JVaughn, David JVaughn, David JVaughn, David JVaughn, David JBeard, ClairBeard, ClairBeard, ClairBeard, ClairHuddart, Robert AHuddart, Robert AHuddart, Robert AHuddart, Robert AKim, JeriKim, JeriKim, JeriKim, JeriKollmannsberger, ChristianKollmannsberger, ChristianKollmannsberger, ChristianKollmannsberger, ChristianSahasrabudhe, Deepak MSahasrabudhe, Deepak MSahasrabudhe, Deepak MSahasrabudhe, Deepak MCook, RyanCook, RyanCook, RyanCook, RyanFossa, Sophie DFossa, Sophie DFossa, Sophie DFossa, Sophie DEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HTravis, Lois BTravis, Lois BTravis, Lois B and Travis, Lois B
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 36, (no. 15), pp. 1512, 2018-May-20. | Journal Article
2017
Altered metabolite levels and correlations in patients with colorectal cancer and polyps detected using seemingly unrelated regression analysis
Chen, ChenChen, ChenChen, ChenChen, ChenChen, ChenNagana Gowda, G ANagana Gowda, G. A.Gowda, G A NaganaNagana Gowda, GNagana Gowda, GZhu, JiangjiangZhu, JiangjiangZhu, JiangjiangZhu, JiangjiangZhu, JiangjiangDeng, LingliDeng, LingliDeng, LingliDeng, LingliDeng, LingliGu, HaiweiGu, HaiweiGu, HaiweiGu, HaiweiGu, HaiweiChiorean, E. GabrielaChiorean, EChiorean, E GabrielaChiorean, EChiorean, E GAbu Zaid, MohammadZaid, Mohammad AbuAbu Zaid, MohammadAbu Zaid, MohammadAbu Zaid, MohammadHarrison, MariettaHarrison, MariettaHarrison, MariettaHarrison, MariettaHarrison, MariettaZhang, DabaoZhang, DabaoZhang, DabaoZhang, DabaoZhang, DabaoZhang, MinZhang, MinZhang, MinZhang, MinZhang, MinRaftery, DanielRaftery, DanielRaftery, DanielRaftery, Daniel and Raftery, Daniel
Metabolomics, vol. 13, (no. 11), pp. 10, 20171100. | Journal Article
 
Immunotherapeutic Concepts to Target Acute Myeloid Leukemia: Focusing on the Role of Monoclonal Antibodies, Hypomethylating Agents and the Leukemic Microenvironment
Gbolahan, Olumide BabajideGbolahan, Olumide BabajideGbolahan, Olumide BabajideZeidan, Amer MZeidan, Amer MZeidan, Amer MZeidan, Amer MStahl, MaximilianStahl, MaximilianStahl, MaximilianStahl, MaximilianAbu Zaid, MohammadAbu Zaid, MohammadAbu Zaid, MohammadFarag, SherifFarag, SherifFarag, SherifFarag, SherifPaczesny, SophiePaczesny, SophiePaczesny, SophiePaczesny, SophieKonig, HeikoKonig, HeikoKonig, Heiko and Konig, Heiko
International journal of molecular sciences, vol. 18, (no. 8), pp. 1660, 2017-Jul-31. | Journal Article
 
Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy
Fung, ChunkitFung, ChunkitFung, ChunkitSesso, Howard DSesso, Howard DSesso, Howard DWilliams, Annalynn MWilliams, Annalynn MWilliams, Annalynn MKerns, Sarah LKerns, Sarah LKerns, Sarah LMonahan, PatrickMonahan, PatrickMonahan, PatrickAbu Zaid, MohammadAbu Zaid, MohammadAbu Zaid, MohammadFeldman, Darren RFeldman, Darren RFeldman, Darren RHamilton, Robert JHamilton, Robert JHamilton, Robert JVaughn, David JVaughn, David JVaughn, David JBeard, Clair JBeard, Clair JBeard, Clair JKollmannsberger, Christian KKollmannsberger, Christian KKollmannsberger, Christian KCook, RyanCook, RyanCook, RyanAlthouse, SandraAlthouse, SandraAlthouse, SandraArdeshir-Rouhani-Fard, ShirinArdeshir-Rouhani-Fard, ShirinArdeshir-Rouhani-Fard, ShirinLipshultz, Steve ELipshultz, Steve ELipshultz, Steve EEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HFossa, Sophie DFossa, Sophie DFossa, Sophie DTravis, Lois BTravis, Lois B and Travis, Lois B
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 35, (no. 11), pp. 1222, 2017-Apr-10. | Journal Article
 
Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post–allogeneic HCT
Abu Zaid, MohammadAbu Zaid, MohammadWu, JuanWu, JuanWu, CindyWu, CindyLogan, Brent RLogan, Brent RYu, JeffreyYu, JeffreyCutler, CoreyCutler, CoreyAntin, Joseph HAntin, Joseph HPaczesny, SophiePaczesny, SophieChoi, Sung Won and Choi, Sung Won
Blood, vol. 129, (no. 2), pp. 170, 2017-01-12. | Journal Article
2016
Biomarker Panel for Chronic Graft-Versus-Host Disease
Yu, JeffreyYu, JeffreyStorer, Barry EStorer, Barry EKushekhar, KushiKushekhar, KushiAbu Zaid, MohammadAbu Zaid, MohammadZhang, QingZhang, QingGafken, Philip RGafken, Philip ROgata, YukoOgata, YukoMartin, Paul JMartin, Paul JFlowers, Mary EFlowers, Mary EHansen, John AHansen, John AArora, MuktaArora, MuktaCutler, CoreyCutler, CoreyJagasia, MadanJagasia, MadanPidala, JosephPidala, JosephHamilton, Betty KHamilton, Betty KChen, George LChen, George LPusic, IskraPusic, IskraLee, Stephanie JLee, Stephanie JPaczesny, Sophie and Paczesny, Sophie
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 34, (no. 22), pp. 2590, 2016-08-01. | Journal Article
 
CXCL10: most consistent cGVHD biomarker?
Paczesny, SophiePaczesny, SophieAbu Zaid, Mohammad and Abu Zaid, Mohammad
Blood, vol. 127, (no. 24), pp. 2951, 2016-06-16. | Journal Article
2015
Targeted serum metabolite profiling and sequential metabolite ratio analysis for colorectal cancer progression monitoring
Zhu, JiangjiangZhu, JiangjiangZhu, JiangjiangDjukovic, DanijelDjukovic, DanijelDjukovic, DanijelDeng, LingliDeng, LingliDeng, LingliGu, HaiweiGu, HaiweiGu, HaiweiHimmati, FarhanHimmati, FarhanHimmati, FarhanAbu Zaid, MohammadAbu Zaid, MohammadAbu Zaid, MohammadChiorean, ElenaChiorean, Elena GabrielaChiorean, Elena GRaftery, DanielRaftery, Daniel and Raftery, Daniel
Analytical and bioanalytical chemistry, vol. 407, (no. 26), pp. 7863, 2015-Oct. | Journal Article
1900
Exploring Metabolic Profile Differences between Colorectal Polyp Patients and Controls Using Seemingly Unrelated Regression
Chen, ChenChen, ChenChen, ChenDeng, LingliDeng, LingliDeng, LingliWei, SiweiWei, SiweiWei, SiweiNagana Gowda, G ANagana Gowda, G. ANagana Gowda, G. AGu, HaiweiGu, HaiweiGu, HaiweiChiorean, Elena GChiorean, Elena GChiorean, Elena GAbu Zaid, MohammadAbu Zaid, MohammadAbu Zaid, MohammadHarrison, Marietta LHarrison, Marietta LHarrison, Marietta LPekny, Joseph FPekny, Joseph FPekny, Joseph FLoehrer, Patrick JLoehrer, Patrick JLoehrer, Patrick JZhang, DabaoZhang, DabaoZhang, DabaoZhang, MinZhang, MinZhang, MinRaftery, DanielRaftery, Daniel and Raftery, Daniel
Journal of Proteome Research, vol. 14, (no. 6), pp. 2499, 00000000. | Journal Article